Alnylam Pharmaceuticals reported $73.43M in Trade Creditors for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Agios Pharmaceuticals AGIO:US $ 16.7M 6.39M
Arrowhead Research ARWR:US $ 10.6M 6.54M
Avrobio Inc AVRO:US 4.04M 551K
Mirati Therapeutics MRTX:US $ 27.94M 7.22M
Regulus Therapeutics RGLS:US $ 0.62M 0.34M
Sangamo Biosciences SGMO:US 11.15M 1.39M